Nanochon closes $4.1M Seed Prime II Funding Round
WASHINGTON, January 12, 2026 — Nanochon, a Washington, DC-based orthopedic device company developing an implant for treating articular cartilage defects […]
WASHINGTON, January 12, 2026 — Nanochon, a Washington, DC-based orthopedic device company developing an implant for treating articular cartilage defects […]
Washington, DC, July 14 2025 – Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant
LOS ANGELES-MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced its 2024 Accelerator Cohort. After a competitive selection
WASHINGTON–Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies